Desloratadine/pseudoephedrine
From Wikipedia, the free encyclopedia
Combination of | |
---|---|
Desloratadine | Antihistamine |
Pseudoephedrine | Alpha-adrenergic agonist |
Clinical data | |
Trade names | Clarinex-D, Aerinaze |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data |
|
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.[1][2]
Desloratadine/pseudoephedrine was approved for use in the United States in 2005[1][3] and in the European Union in July 2007.[2]
Medical uses[]
Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.[2]
References[]
- ^ a b c "Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release". DailyMed. 15 March 2019. Retrieved 1 March 2020.
- ^ a b c d "Aerinaze EPAR". European Medicines Agency. Retrieved 1 March 2020.
- ^ "Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605". U.S. Food and Drug Administration (FDA). 9 May 2007. Retrieved 1 March 2020.
Further reading[]
- Anolik R (June 2009). "Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion". Expert Opin Drug Metab Toxicol. 5 (6): 683–94. doi:10.1517/17425250902980187. PMID 19473112. S2CID 22633518.
External links[]
- "Desloratadine mixture with pseudoephedrine". Drug Information Portal. U.S. National Library of Medicine.
Antihistamines (R06) | |
---|---|
Benzimidazoles (*) |
|
Diarylmethanes |
|
Ethylenediamines |
|
Tricyclics |
|
Others |
|
For topical use |
|
Histamine receptor modulators | |||||
---|---|---|---|---|---|
H1 |
| ||||
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors |
Monoamine releasing agents | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRAs |
| ||||||||||||||
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Tricyclics | |
---|---|
Classes |
|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants |
|
Others |
|
Portal:
Medicine
This drug article relating to the respiratory system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Amphetamine alkaloids
- Benzocycloheptapyridines
- Chloroarenes
- Decongestants
- H1 receptor antagonists
- Human drug metabolites
- Methamphetamine
- Norepinephrine releasing agents
- Peripherally selective drugs
- Phenylethanolamines
- Piperidines
- Respiratory system drug stubs
Hidden categories:
- Use dmy dates from March 2020
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles